BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Zingiber officinale Roscoe {ginger} - Klebsiella pneumoniae PR04 |
👶
Synergetic antimicrobial effects of mixtures of ethiopian honeys and ginger powder extracts on standard and resistant clinical bacteria isolates. Evidence-based complementary and alternative medicine : eCAM (Evid Based Complement Alternat Med ) Vol: 2014 Issue Pages: 562804 Pub: 2014 Epub: 2014 Mar 17 Authors Ewnetu Y , Lemma W , Birhane N , Html Article Publication |
| Zingiber officinale Roscoe {ginger} - Klebsiella pneumoniae PR04 |
👶
Zingiber officinale Uncovered: Integrating Experimental and Computational Approaches to Antibacterial and Phytochemical Profiling. Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 17 Issue 11 Pages: Pub: 2024 Nov 19 Epub: 2024 Nov 19 Authors Sulieman AME , Ibrahim SM , Alshammari M , Abdulaziz F , Idriss H , Alanazi NAH , Abdallah EM , Siddiqui AJ , Shommo SAM , Jamal A , Badraoui R , Html Article Publication |
| Zingiber officinale Roscoe {ginger} - Klebsiella pneumoniae PR04 |
👶
Molecular docking, molecular dynamics simulation, and MM/PBSA analysis of ginger phytocompounds as a potential inhibitor of AcrB for treating multidrug-resistant Klebsiella pneumoniae infections. Journal of biomolecular structure & dynamics (J Biomol Struct Dyn ) Vol: Issue Pages: 1-17 Pub: 2024 Jan 2 Epub: 2024 Jan 2 Authors Sahoo M , Behera DU , Gaur M , Subudhi E , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
